title: Human immunodeficiency virus-type 1 specific cellular immunity in chronic infected patients on prolonged highly active antiretroviral treatment and on structured treatment interruption.
abstract: We have followed 15 HIV-1 chronically infected patients during prolonged highly active antiretroviral treatment (HAART) and subsequent long term structured treatment interruption (STI). We analyzed Nef, Tat, and p24 specific cellular immunity using IFN-gamma enzyme-linked immunospot assays and T cell proliferation assays. Eight HAART patients showed IFN-gamma responses to at least one antigen, but no positive responses were seen during STI. We observed retained or increased p24 specific IFN-gamma responses in most patients during HAART with viral suppression. These results showed persisting HIV-1 specific cellular immunity during HAART; however, in prolonged STI with viral rebound this immunity declined.
authors.affiliation: Swedish Institute for Infectious Disease Control, Microbiology and Tumor Biology Center, Karolinska Institute, Novelsvägen, Solna, Sweden. reikeim@hotmail.com
authors.forename: Reikei
authors.initials: R
authors.lastname: Matsuda
authors.forename: Ann-Charlotte
authors.initials: AC
authors.lastname: Boström
authors.forename: Malin
authors.initials: M
authors.lastname: Fredriksson
authors.forename: Eva-Lena
authors.initials: EL
authors.lastname: Fredriksson
authors.forename: Göran
authors.initials: G
authors.lastname: Bratt
authors.forename: Bo
authors.initials: B
authors.lastname: Hejdeman
authors.forename: Eric
authors.initials: E
authors.lastname: Sandström
authors.forename: Kenji
authors.initials: K
authors.lastname: Okuda
authors.forename: Britta
authors.initials: B
authors.lastname: Wahren
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D018791:CD4 Lymphocyte Count; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D004334:Drug Administration Schedule; D004797:Enzyme-Linked Immunosorbent Assay; D015693:Gene Products, nef / Q000276:immunology; D015696:Gene Products, tat / Q000276:immunology; D016655:HIV Core Protein p24 / Q000276:immunology; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D007371:Interferon-gamma / Q000276:immunology; D008213:Lymphocyte Activation; D013601:T-Lymphocytes / Q000276:immunology; D019562:Viral Load; D054311:nef Gene Products, Human Immunodeficiency Virus; D054322:tat Gene Products, Human Immunodeficiency Virus
chemical_list: D019380:Anti-HIV Agents; D015693:Gene Products, nef; D015696:Gene Products, tat; D016655:HIV Core Protein p24; D054311:nef Gene Products, Human Immunodeficiency Virus; D054322:tat Gene Products, Human Immunodeficiency Virus; D007371:Interferon-gamma